[144] Anterix Inc. SEC Filing
Rhea-AI Filing Summary
The filing is a Form 144 notice reporting proposed sales of Common stock by an issuer-affiliated account and related option exercise activity. The entry list shows multiple restricted stock entries and a Stock Option Exercise on 06/17/2026 with a quantity of 1,226 shares; other listed quantities include 554, 459, 541, 905 and 606 shares tied to various grant or vesting dates.
The header also includes numeric fields shown as 341134.50 and 18732889 alongside a broker address and the exchange NASDAQ; the document lists the broker as Morgan Stanley Smith Barney LLC. This filing reports planned dispositions and related issuer-side exercises/vesting; timing and full proceeds treatment are the items shown in the listed rows.
Positive
- None.
Negative
- None.
Insights
Form 144 lists multiple restricted-stock vestings and a stock-option exercise with planned sales.
The excerpt enumerates restricted stock entries dated 05/15/2025, 07/12/2025, 08/15/2025, 10/04/2025, 05/15/2026, and a Stock Option Exercise on 06/17/2026 for 1,226 shares. These rows identify transaction types ("Restricted Stock" and "Stock Option Exercise") and per-row share counts as provided.
Broker information appears as Morgan Stanley Smith Barney LLC with an address and the exchange listed as NASDAQ. The filing lists numeric fields 341134.50 and 18732889 in the header; the excerpt does not label those numbers within the visible text, so they are reported here only as shown. Cash or net-proceeds treatment beyond the "Cash" label on the 06/17/2026 exercise line is not elaborated in the provided excerpt.